HOME > TOP STORIES
TOP STORIES
-
BUSINESS Fujifilm to Start PII Avigan Trial for COVID-19 in US
April 10, 2020
-
BUSINESS Nichi-Iko Recalling 12 APIs/15 Products over Quality, Compliance Issues
April 9, 2020
-
REGULATORY Should Japan Go Ahead with Off-Year Re-Pricing amid COVID-19 Outbreak? Chuikyo Members Want It Discussed
April 9, 2020
-
BUSINESS Chugai to Launch Actemra PIII Trial for Coronavirus
April 9, 2020
-
REGULATORY Japan Books 13.9 Billion Yen to Boost Avigan Stockpile, Abe Vows to Expand Access to Fujifilm Drug
April 8, 2020
-
BUSINESS Rush to BCG Vaccine for COVID-19 Leads to Curbs on Shipments
April 7, 2020
-
BUSINESS Big 3 Generic Maker Curbing Valsartan Shipments amid India Lockdown
April 6, 2020
-
REGULATORY Japan’s Stimulus Package Likely to Support API Manufacturing Repatriation, Vaccine/Drug Development
April 3, 2020
-
REGULATORY Gilead-Sponsored Remdesivir Trial Expected to Start This Month: Minister
April 3, 2020
-
BUSINESS Amgen Kicks Off Stand-Alone Biz in Japan, Eyes Simultaneous Launch of Full Pipeline
April 2, 2020
-
BUSINESS Fujifilm Launches Avigan Trial with Completion Eyed in June; Sanofi Too to Test Kevzara in Japan
April 1, 2020
-
BUSINESS Fujifilm Wants to Launch Avigan Trial in Japan by End of This Week, Abe Talks to WHO Chief
March 31, 2020
-
REGULATORY Global Health Confab Issues Proposals for Regulatory Harmonization in Asia
March 31, 2020
-
BUSINESS Daiichi Sankyo Files Yescarta, Second CAR-T Therapy in Japan
March 30, 2020
-
REGULATORY New Stable Supply Panel Wants to Define “Key Drugs” by This Summer
March 30, 2020
-
REGULATORY PM Abe Says Japan to Start Registration Trial for Avigan for COVID-19, Plans Production Boost
March 30, 2020
-
REGULATORY Social Security Council at Odds over Future CEA Use, but Agrees to Watch Chuikyo Debate
March 27, 2020
-
REGULATORY Japan OKs Enhertu, 3 Sakigake Drugs, Beovu, Latuda, and More
March 26, 2020
-
REGULATORY Pharma, Healthcare Circle See “Off-Year” Drug Re-Pricing Unrealistic amid Coronavirus Crisis
March 25, 2020
-
BUSINESS Novartis Japan to Shed Oncology Staffers amid Overall Downscaling
March 24, 2020
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
